Compile Data Set for Download or QSAR
Report error Found 207 Enz. Inhib. hit(s) with all data for entry = 1897
TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346269(US10202377, Compound 1)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346270(US10202377, Compound 7)
Affinity DataEC50:  17nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346271(US10202377, Compound 13)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346272(US10202377, Compound 20)
Affinity DataEC50:  10nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346273(US10202377, Compound 25)
Affinity DataEC50:  48nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346274(US10202377, Compound 28)
Affinity DataEC50:  741nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346275(US10202377, Compound 34)
Affinity DataEC50:  47nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346276(US10202377, Compound 40)
Affinity DataEC50:  78nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346277(US10202377, Compound 46)
Affinity DataEC50:  94nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346278(US10202377, Compound 52)
Affinity DataEC50:  147nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346279(US10202377, Compound 55)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346280(US10202377, Compound 61)
Affinity DataEC50:  81nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346281(US10202377, Compound 68)
Affinity DataEC50:  1.67E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346282(US10202377, Compound 73)
Affinity DataEC50:  1.19E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346283(US10202377, Compound 82)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346284(US10202377, Compound 87)
Affinity DataEC50:  124nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346285(US10202377, Compound 90)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346286(US10202377, Compound 93)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346287(US10202377, Compound 101)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346288(US10202377, Compound 109)
Affinity DataEC50:  29nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346290(US10202377, Compound 126)
Affinity DataEC50:  9.99E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346291(US10202377, Compound 136)
Affinity DataEC50:  122nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346292(US10202377, Compound 141)
Affinity DataEC50:  39nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346293(US10202377, Compound 148)
Affinity DataEC50:  225nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346294(US10202377, Compound 154)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346295(US10202377, Compound 157)
Affinity DataEC50:  99nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346296(US10202377, Compound 169)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346297(US10202377, Compound 175)
Affinity DataEC50:  187nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346298(US10202377, Compound 181)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346299(US10202377, Compound 184)
Affinity DataEC50:  277nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346300(US10202377, Compound 190)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346301(US10202377, Compound 196)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346302(US10202377, Compound 202)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346304(US10202377, Compound 211)
Affinity DataEC50:  613nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346306(US10202377, Compound 223)
Affinity DataEC50:  2.61E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346307(US10202377, Compound 229)
Affinity DataEC50:  9.99E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346308(US10202377, Compound 234)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346309(US10202377, Compound 238)
Affinity DataEC50:  57nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346310(US10202377, Compound 244)
Affinity DataEC50:  1.96E+3nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346311(US10202377, Compound 250)
Affinity DataEC50:  258nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346313(US10202377, Compound 265)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346314(US10202377, Compound 268)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346315(US10202377, Compound 269)
Affinity DataEC50:  49nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346316(US10202377, Compound 271)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346317(US10202377, Compound 277)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346319(US10202377, Compound 283)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346320(US10202377, Compound 288)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346321(US10202377, Compound 292)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346322(US10202377, Compound 294)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandPNGBDBM346323(US10202377, Compound 295)
Affinity DataEC50:  249nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 207 total ) | Next | Last >>
Jump to: